C Bressac

1.7k total citations
17 papers, 1.3k citations indexed

About

C Bressac is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C Bressac has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in C Bressac's work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Treatment and Pharmacology (5 papers). C Bressac is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Treatment and Pharmacology (5 papers). C Bressac collaborates with scholars based in France and Switzerland. C Bressac's co-authors include H Brandone, Daniel Hans, Y Aymé, J M Spitalier, R. Amalric, John M. Kurtz, Jocelyne Jacquemier, Jocelyne Jacquemier, Julia Kurtz and Jakob Roth and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

C Bressac

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Bressac France 10 1.2k 804 534 376 171 17 1.3k
Daniel Hans France 9 1.1k 1.0× 805 1.0× 515 1.0× 380 1.0× 158 0.9× 18 1.3k
Pamela H. Craig United States 8 790 0.7× 684 0.9× 370 0.7× 248 0.7× 63 0.4× 10 965
J. A. Andersen Denmark 5 472 0.4× 285 0.4× 300 0.6× 150 0.4× 100 0.6× 9 651
Gregory M. Senofsky United States 9 792 0.7× 635 0.8× 359 0.7× 351 0.9× 55 0.3× 12 942
Leela Elavathil Canada 14 435 0.4× 252 0.3× 351 0.7× 119 0.3× 44 0.3× 25 672
Emanuela Di Re Italy 10 276 0.2× 249 0.3× 246 0.5× 313 0.8× 39 0.2× 15 784
Adrian Murray Brunt United Kingdom 14 344 0.3× 171 0.2× 372 0.7× 127 0.3× 37 0.2× 50 752
Shoshu Mitsuyama Japan 16 293 0.3× 216 0.3× 337 0.6× 143 0.4× 112 0.7× 82 737
J.L. Achard France 12 398 0.3× 206 0.3× 304 0.6× 106 0.3× 55 0.3× 31 630
A.H. Tulusan Germany 9 452 0.4× 210 0.3× 387 0.7× 96 0.3× 40 0.2× 22 637

Countries citing papers authored by C Bressac

Since Specialization
Citations

This map shows the geographic impact of C Bressac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Bressac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Bressac more than expected).

Fields of papers citing papers by C Bressac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Bressac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Bressac. The network helps show where C Bressac may publish in the future.

Co-authorship network of co-authors of C Bressac

This figure shows the co-authorship network connecting the top 25 collaborators of C Bressac. A scholar is included among the top collaborators of C Bressac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Bressac. C Bressac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cals, L., X. Tchiknavorian, Nadine Dohollou, et al.. (2006). Non-pegylated liposomal doxorubicin and docetaxel as front line treatment in HER2-neu negative metastatic breast cancer: Safety and efficacy results. Journal of Clinical Oncology. 24(18_suppl). 10659–10659. 3 indexed citations
2.
Brandone, H, Y Aymé, Daniel Hans, et al.. (1995). [Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)].. PubMed. 49(1). 56–61. 2 indexed citations
3.
Viens, Patrice, Didier Blaise, A.-M. Stoppa, et al.. (1992). Interleukin-2 in Association with Increasing Doses of Interferon-Gamma in Patients with Advanced Cancer. Journal of Immunotherapy. 11(3). 218–224. 3 indexed citations
4.
Kurtz, John M., Jocelyne Jacquemier, R Amalric, et al.. (1991). Is breast conservation after local recurrence feasible?. European Journal of Cancer and Clinical Oncology. 27(3). 240–244. 86 indexed citations
5.
Jacquemier, Jocelyne, et al.. (1991). Inoperable recurrence after breast-conserving surgical treatment and radiotherapy.. PubMed. 172(5). 357–61. 21 indexed citations
6.
Romain, S, F. Spyratos, Y Aymé, et al.. (1991). [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk].. PubMed. 78(8). 709–23. 3 indexed citations
7.
Kurtz, Julia, Jocelyne Jacquemier, R. Amalric, et al.. (1990). Why are local recurrences after breast-conserving therapy more frequent in younger patients?. Journal of Clinical Oncology. 8(4). 591–598. 205 indexed citations
8.
Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1990). The prognostic significance of late local recurrence after breast-conserving therapy. International Journal of Radiation Oncology*Biology*Physics. 18(1). 87–93. 145 indexed citations
9.
Kurtz, John M., Jocelyne Jacquemier, R. Amalric, et al.. (1990). Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 65(8). 1867–1878. 157 indexed citations
10.
Jacquemier, Jocelyne, et al.. (1990). Breast-conserving Therapy for Macroscopically Multiple Cancers. Annals of Surgery. 212(1). 38–44. 156 indexed citations
11.
Romain, S, et al.. (1990). [Prognostic value of thymidine kinase in cancer of the breast].. PubMed. 77(10). 973–83. 9 indexed citations
12.
Romain, S, et al.. (1990). [Cathepsin D: an independent prognostic factor in cancer of the breast].. PubMed. 77(5). 439–47. 29 indexed citations
13.
Kurtz, John M., R. Amalric, H Brandone, et al.. (1989). Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 63(10). 1912–1917. 341 indexed citations
14.
Kurtz, Julia, J M Spitalier, R Amalric, et al.. (1989). Time Course and Prognosis of Mammary Failure Following Breast-Conserving Therapy. Recent results in cancer research. 115. 77–82. 1 indexed citations
15.
Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1988). Mammary recurrences in women younger than forty. International Journal of Radiation Oncology*Biology*Physics. 15(2). 271–276. 102 indexed citations
16.
Spitalier, J M, H Brandone, Y Aymé, et al.. (1986). Breast‐conserving surgery with radiation therapy for operable mammary carcinoma: A 25‐year experience. World Journal of Surgery. 10(6). 1014–1019. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026